Conference Overview
Despite significant advances in our understanding of the pathophysiology and treatment of asthma, and the availability of national and international guidelines on the diagnosis and treatment of asthma, recent surveys show that asthma control and morbidity have not improved. Research is being conducted to address many of these issues. This conference will bring the latest research developments in this rapidly changing field to health care professionals practicing, researching, and teaching asthma care.
Asthma exists in diverse environments and populations and varies in severity by time and patient. Moreover, based on the results of recent research, asthma is being viewed less as a disease and more as a syndrome with multiple phenotypes and endotypes. The resultant heterogeneity forms the basis for the education and discussion embedded in the International Asthma Conference at Nemacolin, which takes pride in being one of the only conferences in the world dedicated exclusively to asthma. Its purpose is to create a highly interactive educational environment, including the world’s best asthma researchers, teachers, and clinicians, to critique cutting-edge research and translate key research findings into clinical pearls that will benefit patients with asthma.
Target Audience and Learning Objectives
Target Audience:
All practicing allergists/immunologists and pulmonologists
Fellows in allergy/immunology and pulmonary training programs
Primary care physicians who care for asthma patients
Allied health professionals with interest in asthma
Following this conference, participants should be able to:
Coming Soon
Intended Outcome
To positively impact the morbidity and cost of asthma by providing health care practitioners with recommendations on the care of patients with asthma that are based on the most up-to-date research conducted by the world’s leading asthma experts.
Accreditation Statements
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the WVU School of Medicine and Maci’s Teams. The WVU School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The WVU Office of CME designates this live activity for a maximum of TBA AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Non-Physicians
West Virginia University Office of Continuing Education will confirm participation in this educational activity.
Disclosure
It is the policy of the WVU School of Medicine Office of CME to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty/authors/planners participating in our programs are expected to disclose any relevant relationships they may have with commercial companies.
For this conference, any relevant relationships with commercial companies will be coming soon and listed below. All others have indicated they have no relevant interests to disclose.
The relationships, along with the educational content of this program, will be reviewed and any potential conflicts of interest will be resolved to the satisfaction of the WVU School of Medicine Office of CME.
Commercial Support
Coming Soon
Contact
Please contact Jessica Bolton if you have any questions (jbolton@macisteams.org).